Literature DB >> 2227541

Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva.

J M Heaps1, Y S Fu, F J Montz, N F Hacker, J S Berek.   

Abstract

One hundred and thirty-five patients with squamous carcinoma of the vulva were treated at UCLA and City of Hope Medical Centers between 1957 and 1985. Sixty-two cases were stage I, 48 stage II, 18 stage III, and 7 stage IV. Twenty-one patients developed a local vulvar recurrence after primary radical resection. Ninety-one patients had a surgical tumor-free margin greater than or equal to 8 mm on tissue section and none had a local vulvar recurrence. Forty-four patients had a margin less than 8 mm; 21 had a local recurrence and 23 did not (P less than 0.0001). Of the 23 patients with a margin less than 8 mm who did not recur locally, 14 remained free of disease, and 9 had either advanced disease, declining health, or short follow-up. Depth of invasion is associated with local recurrence, with a 9.1-mm reference value correctly predicting outcome in 81.5% of cases. Increasing tumor thickness is associated with local recurrence, with a 10-mm reference value predictive of 90% non-recurrence and 33% recurrences. A pushing border pattern is less likely to recur than an infiltrative growth pattern. Lymph-vascular space invasion has a combined predictive accuracy of 81.5%. Increasing keratin and greater than 10 mitoses per 10 high-power fields correlate with local recurrence. Neither clinical tumor size nor coexisting benign vulvar pathology correlates with local recurrence. Fourteen of twenty-one patients with vulvar recurrence died of metastatic disease, four died of intercurrent disease, and three were alive at 32, 68, and 157 months, with 16 recurring in less than 1 year. Surgical margin is the most powerful predictor of local vulvar recurrence. Combining factors in a stepwise logistical regression does not significantly improve this predictive value. Accounting for specimen preparation and fixation, a 1-cm tumor-free surgical margin on the vulva results in a high rate of local control, whereas a margin less than 8 mm is associated with a 50% chance of recurrence.

Entities:  

Mesh:

Year:  1990        PMID: 2227541     DOI: 10.1016/0090-8258(90)90064-r

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  39 in total

Review 1.  "Unresectable" vulval cancers: is neoadjuvant chemotherapy the way forward?

Authors:  Kathryn Graham; Kevin Burton
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.

Authors:  Sabrina M Bedell; Chloe Hedberg; Anna Griffin; Hannah Pearson; Annelise Wilhite; Nathan Rubin; Britt K Erickson
Journal:  Gynecol Oncol       Date:  2019-06-03       Impact factor: 5.482

3.  Experience with gluteal V-Y fasciocutaneous advancement flaps in vulvar reconstruction after oncological resection and a modification to the marking: Playing with tension lines.

Authors:  Alessandra Fin; Emanuele Rampino Cordaro; Gianni F Guarneri; Susanna Revesz; Michele Vanin; Pier C Parodi
Journal:  Int Wound J       Date:  2018-10-10       Impact factor: 3.315

4.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

Review 5.  Advanced Vulvar Cancers: What are the Best Options for Treatment?

Authors:  Alejandro Soderini; Alejandro Aragona; Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2016-10       Impact factor: 5.075

Review 6.  Surgical interventions for early squamous cell carcinoma of the vulva.

Authors:  A Ansink; J van der Velden
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma.

Authors:  David K Gaffney; Bronwyn King; Akila N Viswanathan; Maroie Barkati; Sushil Beriwal; Patricia Eifel; Beth Erickson; Anthony Fyles; Jennifer Goulart; Matthew Harkenrider; Anuja Jhingran; Ann Klopp; Wui-Jin Koh; Karen Lim; Ivy Petersen; Lorraine Portelance; William Small; Alexandra Stewart; Ericka Wiebe; Aaron Wolfson; Catheryn Yashar; Walter Bosch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-21       Impact factor: 7.038

8.  [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva].

Authors:  L-C Horn; K Schierle; K Klostermann; H-G Schnürch; P Hantschmann
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

Review 9.  Vulvar carcinoma.

Authors:  R L Coleman; J T Santoso
Journal:  Curr Treat Options Oncol       Date:  2000-06

10.  Validation of a nomogram for predicting outcome of vulvar cancer patients, primarily treated by surgery, in Korean population: multicenter retrospective study through Korean Gynecologic Oncology Group (KGOG-1010).

Authors:  Mi-Kyung Kim; Jae Weon Kim; Jong-Min Lee; Nak-Woo Lee; Moon-Seok Cha; Byoung-Gie Kim; Ki Heon Lee; Young-Tae Kim; Jae-Hoon Kim; Eun-Seop Song; Moon-Hong Kim; Sang-Young Ryu; Won Gyu Kim; Young-Tak Kim; Kyung-Tai Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.